Advertisement

Refraktive Hornhautchirurgie trotz systemischer Erkrankungen?

  • A. FringsEmail author
  • N. Ardjomand
  • T. Katz
  • S. J. Linke
  • J. Steinberg
Das diagnostische und therapeutische Prinzip
  • 25 Downloads

Zusammenfassung

Es existiert laut Literatur eine Vielzahl von potenziellen systemischen Kontraindikationen für korneal refraktiv-chirurgische Verfahren. In Fällen mit relativen Kontraindikationen darf der Eingriff nur unter Abwägung der individuellen Risiken und unter stabilen Krankheitsbedingungen erfolgen. Die „Evidenz“ vieler dieser Kontraindikationen basiert aber nur auf Fallberichten oder -serien, Expertenmeinungen oder bekannten Komplikationen bei nicht lasergestützten Augenoperationen. Randomisierte klinische Studien sind daher erforderlich.

Schlüsselwörter

Kontraindikation Laser-in-situ-Keratomileusis Autoimmunerkrankungen Hauterkrankungen Medikamente 

Corneal refractive surgery despite systemic diseases?

Abstract

According to the literature there are a large number of potential systemic contraindications for corneal refractive surgery. In cases with relative contraindications, surgery should be performed only after weighing up the individual risks and under controlled disease conditions; however, the “evidence” for many of these contraindications is based only on case reports or series, expert opinions or known complications in non-laser-assisted eye surgery. Randomized clinical trials are therefore required.

Keywords

Contraindication Laser in situ keratomileusis Autoimmune diseases Skin diseases Drugs 

Notes

Förderung

Diese Arbeit wurde von der Ernst- und Berta-Grimmke-Stiftung gefördert.

Einhaltung ethischer Richtlinien

Interessenkonflikt

A. Frings, N. Ardjomand, T. Katz, S.J. Linke und J. Steinberg geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    Alió JL, Artola A, Belda JI, Perez-Santonja JJ, Muñoz G, Javaloy J, Rodríguez-Prats JL, Galal A (2005) LASIK in patients with rheumatic diseases. A pilot study. Ophthalmology 112:1948–1954CrossRefGoogle Scholar
  2. 2.
    Aman-Ullah M, Gimbel HV, Purba MK, van Westenbrugge JA (2012) Necrotizing keratitis after laser refractive surgery in patients with inactive inflammatory bowel disease. Case Rep Ophthalmol 3:54–60CrossRefGoogle Scholar
  3. 3.
    Artola A, Gala A, Belda JI, Pérez-Santonja JJ, Rodriguez-Prats JL, Ruiz-Moreno JM, Alió JL (2006) LASIK in myopic patients with dermatological keloids. J Refract Surg 22:505–508CrossRefGoogle Scholar
  4. 4.
    Bower KS, Woreta F (2014) Update on contraindications for laser-assisted in situ keratomileusis and photorefractive keratectomy. Curr Opin Ophthalmol 25:251–257CrossRefGoogle Scholar
  5. 5.
    Cobo-Soriano R, Beltran J, Baviera J (2006) LASIK outcomes in patients with underlying systemic contraindications. A preliminary study. Ophthalmology 113:1118–1124CrossRefGoogle Scholar
  6. 6.
    Conroy MA, Duran PA, Avery JD (2016) A Case of New-Onset Psychosis Following Laser In Situ Keratomileusis (LASIK) Eye Surgery. Prim Care Companion Cns Disord 22:18Google Scholar
  7. 7.
    Cua IY, Pepose JS (2002) Late corneal scarring after photorefractive keratectomy concurrent with development of systemic lupus erythematosus. J Refract Surg 18:750–752PubMedGoogle Scholar
  8. 8.
    O’Doherty MA, O’Doherty JV, O’Keefe M (2006) Outcome of LASIK for myopia in women on hormone replacement therapy. J Refract Surg 22:350–353CrossRefGoogle Scholar
  9. 9.
    Engelhard SB, Shah CT, Sim AJ, Reddy AK (2018) Malpractice Litigation in Cornea and Refractive Surgery: A Review of the WestLaw Database. Cornea 37:537–541CrossRefGoogle Scholar
  10. 10.
    Fraunfelder FW, Rich LF (2002) Laser-assisted in situ keratomileusis complications in diabetes mellitus. Cornea 21:246–248CrossRefGoogle Scholar
  11. 11.
    Ghaffariyeh A, Chamacham T (2008) Tricyclic antidepressants: potential therapeutic alternatives for treatment of dry eye symptoms after LASIK. J Refract Surg 24:770–771PubMedGoogle Scholar
  12. 12.
    Girgis R, Morris DS, Kotagiri A, Ramaesh K (2007) Bilateral corneal scarring after LASIK and PRK in a patient with propensity to keloid scar formation. Eye (Lond) 21:96–97CrossRefGoogle Scholar
  13. 13.
    Gotovac M, Kastelan S, Lukenda A (2013) Eye and pregnancy. Coll Antropol 37:189–193PubMedGoogle Scholar
  14. 14.
    Hagen KB, Kettering JD, Aprecio RM, Beltran F, Maloney RK (1997) Lack of virus transmission by the excimer laser plume. Am J Ophthalmol 124:206–211CrossRefGoogle Scholar
  15. 15.
    Halkiadakis I, Belfair N, Gimbel HV (2005) Laser in situ keratomileusis in patients with diabetes. J Cataract Refract Surg 31:1895–1898CrossRefGoogle Scholar
  16. 16.
    Hardten DR, Hira NK, Lombardo AJ (2005) Triptans and the incidence of epithelial defects during laser in situ keratomileusis. J Refract Surg 21:72–76PubMedGoogle Scholar
  17. 17.
    Hovanesian JA, Faktorovich EG, Hoffbauer JD, Shah SS, Maloney RK (1999) Bilateral bacterial keratitis after laser in situ keratomileusis in a patient with human immunodeficiency virus infection. Arch Ophthalmol 117:968–970PubMedGoogle Scholar
  18. 18.
    Karalezli A, Borazan M, Altinors DD, Dursun R, Kiyici H, Akova YA (2009) Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin. Cornea 28:46–50CrossRefGoogle Scholar
  19. 19.
    Lahners WJ, Hardten DR, Lindstrom RL (2003) Peripheral keratitis following laser in situ keratomileusis. J Refract Surg 19:671–675PubMedGoogle Scholar
  20. 20.
    Lee JY, Youm DJ, Choi CY (2011) Conventional Epi-LASIK and lamellar epithelial debridement in myopic patients with dermatologic keloids. Korean J Ophthalmol 25:206–209CrossRefGoogle Scholar
  21. 21.
    Liang L, Zhang M, Zou W, Liu Z (2008) Aggravated dry eye after laser in situ keratomileusis in patients with Sjogren syndrome. Cornea 27:120–123CrossRefGoogle Scholar
  22. 22.
    Long Q, Chu R, Zhou X, Dai J, Chen C, Rao SK, Lam DS (2006) Correlation between TGF-beta1 in tears and corneal haze following LASEK and epi-LASIK. J Refract Surg 22:708–712CrossRefGoogle Scholar
  23. 23.
    Mackensen F, Paulus WE, Max R, Ness T (2014) Ocular changes during pregnancy. Dtsch Arztebl Int 111:567–575PubMedPubMedCentralGoogle Scholar
  24. 24.
    Malik M, Simpson RC, Varma S (2011) Isotretinoin as contraindication. BMJ 342:d3353CrossRefGoogle Scholar
  25. 25.
    Mirshahi A, Kohnen T (2003) Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature. J Cataract Refract Surg 29:1026–1030CrossRefGoogle Scholar
  26. 26.
    Moon SJ, Mann PM, Matoba AY (2003) Microsporidial keratoconjunctivitis in a healthy patient with a history of LASIK surgery. Cornea 22:271–272CrossRefGoogle Scholar
  27. 27.
    Morse JS, Schallhorn SC, Hettinger K, Tanzer D (2009) Role of depressive symptoms in patient satisfaction with visual quality after laser in situ keratomileusis. J Cataract Refract Surg 35:341–346CrossRefGoogle Scholar
  28. 28.
    Ortega-Usobiaga J, García-Sáenz MC, Artaloytia-Usobiaga JF, Llovet-Osuna F, Beltrán-Sanz J, Baviera-Sabater J (2012) Myopic LASIK in psychiatric patients. Cornea 31:150–154CrossRefGoogle Scholar
  29. 29.
    Simpson RG, Moshirfar M, Edmonds JN, Christiansen SM (2012) Laser in-situ keratomileusis in patients with diabetes mellitus: a review of the literature. Clin Ophthalmol 6:1665–1674PubMedPubMedCentralGoogle Scholar
  30. 30.
    Smith RJ, Maloney RK (2006) LASIK in patients with autoimmune diseases. J Cataract Refract Surg 32:1292–1295CrossRefGoogle Scholar
  31. 31.
    Spadea L, Paroli MP (2012) Laser refractive surgery in diabetic patients: a review of the literature. Clin Ophthalmol 6:1775–1783CrossRefGoogle Scholar
  32. 32.
    Tanzer DJ, Isfahani A, Schallhorn SC, LaBree LD, McDonnell PJ (1998) Photorefractive keratectomy in African Americans including those with known dermatologic keloid formation. Am J Ophthalmol 126:625–629CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • A. Frings
    • 1
    • 2
    • 3
    Email author
  • N. Ardjomand
    • 4
  • T. Katz
    • 5
    • 6
  • S. J. Linke
    • 5
    • 6
    • 7
  • J. Steinberg
    • 5
    • 6
    • 7
  1. 1.Institute of OphthalmologyUCLLondonGroßbritannien
  2. 2.Univ.-Augenklinik DüsseldorfHeinrich-Heine-UniversitätDüsseldorfDeutschland
  3. 3.CARE Vision NürnbergNürnbergDeutschland
  4. 4.Sehzentrum für Augenlaser & AugenchirurgieGrazÖsterreich
  5. 5.AugenklinikUniversitätsklinikum Hamburg-Eppendorf (UKE)HamburgDeutschland
  6. 6.CARE Vision HamburgHamburgDeutschland
  7. 7.zentrumsehstärke – AugenarztpraxisUKEHamburgDeutschland

Personalised recommendations